US and German Scientists Win Nobel Medicine Prize for Breakthrough Work on Light and the Brain

Two German scientists and an American researcher have won the 2026 Nobel Prize in Physiology or Medicine for discoveries that transformed scientists’ ability to study and control the brain using light.

The Nobel Assembly at the Karolinska Institutet awarded the prize to Karl Deisseroth of the United States and Germany’s Peter Hegemann and Georg Nagel for their discoveries concerning light-gated ion channels and optogenetics.

Nobel Prize Recognises a New Way to Study the Brain

The scientists’ work led to the development of optogenetics, a technique that allows researchers to control the activity of individual nerve cells using light.

The technology has fundamentally changed neuroscience because it allows researchers to switch specific neurons on or off with remarkable precision. This has helped scientists investigate how brain circuits influence memories, emotions and behaviour.

The Nobel Assembly said optogenetics has opened a new era in neuroscience and provides opportunities to map the brain in ways that were previously difficult to achieve.

Discovery Began With Light-Sensitive Algae

The breakthrough began with research into a tiny single-celled alga called Chlamydomonas.

Peter Hegemann was interested in how the organism detects and moves toward light. Hegemann and Georg Nagel discovered a light-sensitive protein called channelrhodopsin.

When exposed to blue light, the protein opens a channel that allows charged ions to move through the cell, creating an electrical signal. Their work showed that the protein could make other cells respond to light.

Deisseroth Turned the Discovery Into a Brain Tool

Karl Deisseroth and his colleagues took the research a major step further by introducing the gene for channelrhodopsin into nerve cells.

In experiments, researchers were able to use blue light to trigger electrical activity in neurons. Deisseroth later demonstrated that the technique could be used in the brains of living animals.

The resulting method became known as optogenetics, combining genetics with the use of light to control nerve-cell activity.

Potential for Neurological and Psychiatric Research

Optogenetics has become an important research tool for studying brain disorders and neural circuits.

Scientists have used the technique to investigate conditions and processes linked to Alzheimer’s disease, Parkinson’s disease, epilepsy, addiction, depression and other neurological or psychiatric disorders.

Researchers are also exploring whether optogenetic approaches could eventually help restore vision in people with certain forms of blindness and contribute to other medical treatments. However, many therapeutic applications remain under development.

Three Scientists Share the Prize

Karl Deisseroth is a professor at Stanford University in California. Peter Hegemann is associated with Humboldt University of Berlin, while Georg Nagel has been associated with the University of Würzburg in Germany.

The three laureates will share the Nobel prize money of 12 million Swedish kronor.

The medicine award opens the 2026 Nobel Prize announcements, with the prizes in physics, chemistry, literature, peace and economic sciences to follow during Nobel week.

The recognition of Deisseroth, Hegemann and Nagel highlights how a discovery involving light-sensitive proteins in algae ultimately became a powerful tool for exploring one of science’s greatest mysteries: how the human brain works.

Source attribution: Nobel Prize, Karolinska Institutet, Reuters, Associated Press, Nature and Stanford/HHMI.